Evidence map›Paper›PMID 19020838›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2009

Multiparameter flow cytometry monitoring of T cell responses.

Holden T Maecker

Abstract read
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Trial
  4. Article
  5. The Biodegradability andFrontiers in bioengineering and biotechnology · 2022
    Article
  6. Article
  7. Article
  8. Human T-Cell Cloning by Limiting Dilution.Methods in molecular biology (Clifton, N.J.) · 2021
    Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Multiparameter Phenotyping of Human PBMCs Using Mass Cytometry.Methods in molecular biology (Clifton, N.J.) · 2015
    Article
  16. Review
  17. Functionality of CD4+ and CD8+ T cells from tonsillar tissue.Clinical and experimental immunology · 2012
    Article
  18. Article
  19. Biomarkers in T cell therapy clinical trials.Journal of translational medicine · 2011
    Review
  20. Multiparameter intracellular cytokine staining.Methods in molecular biology (Clifton, N.J.) · 2011
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Holden T Maecker

Funding

Immunologic Correlates of Immunization for CancerU54CA090818 · NCI · UNIVERSITY OF WASHINGTON · PI DISIS, MARY L. · 2001 to 2006
$5.5M
FLOW CYTOMETRY STUDY OF T CELL RESPONSES TO HIV VACCINESR01AI047062 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MCCUNE, JOSEPH M · 2000 to 2007
$3.6M
NCI NIH HHS U54 CA090818NIAID NIH HHS R01 AI047062
6 · The paper itself

Abstract

HIV vaccine research increasingly uses polychromatic flow cytometry as a tool to monitor T cell responses. The use of this technology allows for the analysis of highly defined subsets of cells with unique phenotypes and functions. Ultimately, such studies may identify surrogate markers of protection from disease progression. However, this powerful technology comes with a number of technical hurdles, and there is a need to standardize the assays and protocols used in clinical trial monitoring. Here an optimized protocol, with variations for specific circumstances, is presented. This protocol covers the analysis of multiple cytokines, cell surface markers, and other functional markers such as perforin, CD107, and CD154. While the protocol can be adapted to various numbers of fluorescence parameters, optimized panels of 8-10 colors are presented.

Indexed as

AIDS VaccinesAntigens, CDCytokinesFlow CytometryHumansT-LymphocytesAIDS VaccinesAntigens, CDCytokines

Identifiers

PMID19020838
PMCPMC4436148

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.